Efficacy of clinically relevant temozolomide dosing schemes in glioblastoma cancer stem cell lines
Article
Beier, Dagmar, Schriefer, Beate, Brawanski, Konstantin, Hau, Peter, Weis, Joachim
, Schulz, Jörg B. and Beier, Christoph P.
(2012)
Efficacy of clinically relevant temozolomide dosing schemes in glioblastoma cancer stem cell lines.
Journal of Neuro-Oncology 109 (1), pp. 45-52.
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Journal of Neuro-Oncology | ||||
| Publisher | SPRINGER | ||||
| Place of Publication | NEW YORK | ||||
| Volume | 109 | ||||
| Number of Issue or Book Chapter | 1 | ||||
| Page Range | pp. 45-52 | ||||
| Date | 2012 | ||||
| Date of publication | 19 Dec 2024 09:38 | ||||
| Institutions | Medicine > Lehrstuhl für Neurologie | ||||
| Identification Number |
| ||||
| Keywords | RECURRENT MALIGNANT GLIOMA; PHASE-II TRIAL; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; GENE-EXPRESSION; TUMOR; PROFILES; O-6-BENZYLGUANINE; CHEMORESISTANCE; RADIOTHERAPY; PHENOTYPE; Temozolomide; Glioblastoma cancer stem cell; MGMT; Temozolomide rechallenge | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 63504 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric